Ismael, Alfadz A.
HRN: 23-26-34 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/21/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
07/21/2023
07/28/2023
IV
1gram
Q6hrs
PCAP C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Non-compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes